How Regenerative Medicine Can Put An End To Pain
the Clinical Pain Advisor take:
Taking a look at the growth in the regenerative medicine market makes some wonder: How can this thriving area put an end to pain?
A Market Research study expects the worldwide regenerative medicine market to reach $24.7 billion by 2017. Going forward, skin/integumentary and urology are expected to support the industry (together the spaces account for approximately 25.97% of the market).
The Mayo Clinic, a medical research firm, considers regenerative medicine to be a "game-changing area of medicine with the potential to fully heal damaged tissues and organs, offering solutions and hope for people who have conditions that today are beyond repair."
In an interview with CNBC, President Edward Britt, president of Applied Biologics, a biotech company that leverages regenerative medicine, said the sector is focused on healing injuries faster. By dedicating time toward this outcome, athletes can "get back on the field, the court or the road quicker and stronger."
The concept of regenerative medicine isn't a new area. Advances, however, in other fields (including developmental and cell biology, and immunology) have opened up doors to new opportunities.
Not everybody feels the same about regenerative medicine. For example, ethical and religious debates have included concerns over stem cell-based medicine, mainly about the use of embryonic cells.
As the regenerative market grows, researchers are looking into new ways to change the way athletes recover from painful injuries by shortening recovery periods.
Clinical Pain Advisor Articles
- Two Screening Tools May Accurately Predict Transition From Acute to Chronic Low Back Pain
- Tools to Address the Opioid Crisis
- Methamphetamine Use on the Rise in Patients With Opioid Use Disorder
- Patterns of Non-Medical Prescription Opioid Use in Adolescents
- Half of the Responders to Our Poll Agree With the Approval of Dsuvia: We Want to Hear From You
- The Unintended Consequences of the CDC Opioid Guideline According to Pain Management Specialists
- Initial Consultation for Neck Pain May Reduce Opioid Consumption, Healthcare Utilization
- FDA-Approved Test Provides Pharmacogenetic Reports Directly to Consumers
- Set of Interventions May Effectively Reduce Opioid Overprescribing
- Cannabinoid-Associated Analgesia May Be Mediated Through Modulation of Affective Processes
- FDA Panel Votes in Favor of Abuse-Deterrent Oxycodone Reformulation
- FDA Proposes New Restrictions on Sale of Electronic Nicotine Delivery Systems
- Central Sensitization in Greater Trochanteric Pain Syndrome
- Pain Acceptance May Reduce Headache-Related Disability in Migraine
- FDA Issues Safety Alert Regarding Intrathecal Delivery of Pain Meds